Related Experiment Video
Updated: May 30, 2026

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
Published on: August 3, 2018
Tumor necrosis factor inhibits mesenchymal stem cell differentiation into osteoblasts via the ubiquitin E3 ligase
Lan Zhao1, Jian Huang, Hengwei Zhang
1Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, New York, USA.
Abstract:
Patients with chronic inflammatory disorders, such as rheumatoid arthritis, often have osteoporosis due to a combination of Tumor necrosis factor-induced increased bone resorption and reduced bone formation. To test if TNF inhibits bone formation by affecting the commitment and differentiation of mesenchymal stem cells (MSCs) into osteoblasts, we examined the osteogenic potential of MSCs from TNF transgenic (TNF-Tg) mice, a model of chronic inflammatory arthritis. MSC-enriched cells were isolated from bone marrow stromal cells using negative selection with anti-CD45 antibody coated magnetic beads. The expression profile of MSC surface markers the osteogenic, chondrogenic, and adipogenic properties of CD45(-) cells were confirmed by FACS and cell differentiation assays. MSC-enriched CD45(-) cells from TNF-Tg mice formed significantly decreased numbers of fibroblast and ALP(+) colonies and had a decreased expression of osteoblast marker genes. As TNF may upregulate ubiquitin ligases, which negatively regulate osteoblast differentiation, we examined the expression levels of several ubiquitin ligases and found that Wwp1 expression was significantly increased in MSC-enriched CD45(-) cells of TNF-Tg mice. Wwp1 knockdown rescued impaired osteoblast differentiation of TNF-Tg CD45(-) cells. Wwp1 promotes ubiquitination and degradation of JunB, an AP-1 transcription factor that positively regulates osteoblast differentiation. Injection of TNF into wild-type mice resulted in decreased osteoblast differentiation of MSCs and increased JunB ubiquitination, which was completely blocked in Wwp1(-/-) mice. Thus, Wwp1 targets JunB for ubiquitination and degradation in MSCs after chronic exposure to TNF, and inhibition of Wwp1 in MSCs could be a new mechanism to limit inflammation-mediated osteoporosis by promoting their differentiation into osteoblasts.
Insights
Tumor necrosis factor (TNF) impairs bone formation by increasing Wwp1 expression, which degrades JunB in mesenchymal stem cells (MSCs). Inhibiting Wwp1 may treat inflammation-related osteoporosis by promoting osteoblast differentiation.
Area of Science:
- Biomedical Science
- Cell Biology
- Rheumatology
Background:
- Chronic inflammatory disorders, like rheumatoid arthritis, are linked to osteoporosis.
- Tumor necrosis factor (TNF) contributes to bone loss by increasing resorption and decreasing formation.
- Mesenchymal stem cells (MSCs) are crucial for bone formation, differentiating into osteoblasts.
Purpose of the Study:
- To investigate if TNF inhibits osteoblast differentiation by affecting MSC commitment.
- To identify molecular mechanisms by which TNF impacts MSC osteogenic potential.
- To explore Wwp1 as a therapeutic target for inflammation-mediated osteoporosis.
Main Methods:
- Isolated MSC-enriched CD45(-) cells from TNF transgenic (TNF-Tg) mice and wild-type controls.
- Utilized flow cytometry (FACS) and cell differentiation assays to assess osteogenic potential.
- Examined gene and protein expression, including ubiquitin ligases like Wwp1 and transcription factors like JunB.
- Performed Wwp1 knockdown and utilized Wwp1 knockout mice for mechanistic studies.
Main Results:
- MSCs from TNF-Tg mice showed significantly reduced osteogenic potential and decreased expression of osteoblast markers.
- Wwp1 expression was significantly increased in MSCs from TNF-Tg mice.
- Wwp1 knockdown rescued the impaired osteoblast differentiation in TNF-Tg MSCs.
- Wwp1 was found to promote ubiquitination and degradation of the osteogenic transcription factor JunB.
- TNF injection in wild-type mice decreased MSC osteoblast differentiation and increased JunB ubiquitination, effects blocked in Wwp1(-/-) mice.
Conclusions:
- Chronic TNF exposure upregulates Wwp1 in MSCs, leading to JunB degradation and impaired osteoblast differentiation.
- Wwp1 acts as a key mediator of TNF-induced inhibition of osteogenesis.
- Targeting Wwp1 in MSCs presents a potential therapeutic strategy to combat inflammation-associated osteoporosis.
More Related Videos
07:05TGF-β-mediated Endothelial to Mesenchymal Transition (EndMT) and the Functional Assessment of EndMT Effectors using CRISPR/Cas9 Gene Editing
Published on: February 26, 2021
11:15A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
Related Concept Videos
Mesenchymal Stem Cells
Canonical Wnt Signaling Pathway
Abnormal Proliferation
The Tumor Microenvironment
Non-Canonical Wnt Signaling Pathways
Stem Cell Niche